China Pharma Holdings (CPHI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2011 | 12-2010 | |
| Sales | 22,134 | 32,807 | 54,507 | 81,167 | 74,388 |
| Cost of Goods | 19,466 | 33,288 | 40,431 | 52,179 | 44,106 |
| Gross Profit | 2,668 | -481 | 14,076 | 28,988 | 30,283 |
| Operating Expenses | 41,892 | 18,413 | 8,744 | 7,443 | 6,193 |
| Operating Income | -38,758 | -18,606 | 5,763 | 21,724 | 24,195 |
| Interest Expense | 786 | 349 | 308 | 255 | 168 |
| Other Income | 70 | 9 | 147 | 1,243 | 2,074 |
| Pre-tax Income | -39,474 | -18,947 | 5,602 | 22,712 | 26,101 |
| Income Tax | 77 | 1,061 | 984 | 3,442 | 2,686 |
| Net Income Continuous | -39,551 | -20,008 | 4,618 | 19,270 | 23,414 |
| Net Income | $-39,551 | $-20,008 | $4,618 | $19,270 | $23,414 |
| EPS Basic Total Ops | -455.00 | -230.00 | 55.00 | 220.00 | 270.00 |
| EPS Basic Continuous Ops | -453.77 | -229.56 | 52.98 | 221.59 | 270.19 |
| EPS Diluted Total Ops | -455.00 | -230.00 | 55.00 | 220.00 | 270.00 |
| EPS Diluted Continuous Ops | -453.77 | -229.56 | 52.98 | 221.59 | 268.93 |
| EBITDA(a) | $-36,972 | $-16,994 | $7,226 | $22,899 | $25,700 |